Yuan‐Lin Guo

4.8k total citations · 1 hit paper
156 papers, 3.2k citations indexed

About

Yuan‐Lin Guo is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yuan‐Lin Guo has authored 156 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Surgery, 57 papers in Cardiology and Cardiovascular Medicine and 53 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yuan‐Lin Guo's work include Lipoproteins and Cardiovascular Health (94 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers) and Cancer, Lipids, and Metabolism (24 papers). Yuan‐Lin Guo is often cited by papers focused on Lipoproteins and Cardiovascular Health (94 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers) and Cancer, Lipids, and Metabolism (24 papers). Yuan‐Lin Guo collaborates with scholars based in China, United States and Israel. Yuan‐Lin Guo's co-authors include Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu, Jian‐Jun Li, Sha Li, Jian‐Jun Li, Jing Sun, Ye‐Xuan Cao, Jing‐Lu Jin and Ying Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Yuan‐Lin Guo

151 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Chinese guideline for lipid management

2023 81 citations Jian‐Jun Li, Yuan‐Lin Guo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuan‐Lin Guo China	29	1.8k	1.2k	994	534	428	156	3.2k
Na‐Qiong Wu China	31	1.9k 1.0×	1.2k 1.0×	1.1k 1.1×	572 1.1×	483 1.1×	192	3.3k
Cheng‐Gang Zhu China	31	2.0k 1.1×	1.5k 1.3×	1.2k 1.2×	629 1.2×	423 1.0×	209	3.7k
Rui‐Xia Xu China	33	1.7k 1.0×	1.0k 0.9×	714 0.7×	440 0.8×	630 1.5×	158	3.5k
G. Kees Hovingh Netherlands	30	2.1k 1.2×	1.0k 0.9×	1.3k 1.3×	298 0.6×	646 1.5×	76	3.4k
Eak Kyun Shin South Korea	31	1.3k 0.7×	1.3k 1.1×	1.1k 1.1×	845 1.6×	254 0.6×	123	3.2k
William J. Sasiela United States	21	2.9k 1.6×	1.2k 1.0×	1.0k 1.0×	585 1.1×	716 1.7×	61	3.9k
Mieke D. Trip Netherlands	33	1.8k 1.0×	1.2k 1.0×	1.0k 1.0×	347 0.6×	578 1.4×	70	3.6k
Lixia Jiao United States	14	1.5k 0.8×	796 0.7×	971 1.0×	260 0.5×	231 0.5×	27	3.3k
Masa‐aki Kawashiri Japan	35	2.4k 1.3×	1.5k 1.3×	1.2k 1.2×	473 0.9×	714 1.7×	286	4.6k
Craig Granowitz United States	18	1.6k 0.9×	1.0k 0.9×	1.3k 1.3×	342 0.6×	285 0.7×	55	3.2k

Countries citing papers authored by Yuan‐Lin Guo

Since Specialization

Citations

This map shows the geographic impact of Yuan‐Lin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Lin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Lin Guo more than expected).

Fields of papers citing papers by Yuan‐Lin Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Lin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Lin Guo. The network helps show where Yuan‐Lin Guo may publish in the future.

Co-authorship network of co-authors of Yuan‐Lin Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Lin Guo. A scholar is included among the top collaborators of Yuan‐Lin Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Lin Guo. Yuan‐Lin Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Sha, Yan Zhang, Yan Zhang, et al.. (2025). Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary Syndrome. MedComm. 6(12). e70505–e70505.

Wang, Haoyu, Yuan‐Lin Guo, Ying Gao, et al.. (2025). Residual atherosclerotic risk in older patients with atherosclerotic cardiovascular disease: where inflammation meets lipoprotein(a). Age and Ageing. 54(11).

Peng, Jia, Mingming Liu, Jing‐Lu Jin, et al.. (2022). NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study. Lipids in Health and Disease. 21(1). 3–3. 8 indexed citations

Liu, Huihui, Ye‐Xuan Cao, Jing‐Lu Jin, et al.. (2021). Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study. Cardiovascular Diabetology. 20(1). 84–84. 20 indexed citations

Liu, Mingming, Huihui Liu, Yuan‐Lin Guo, et al.. (2021). Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study. Thrombosis Journal. 19(1). 90–90. 7 indexed citations

Cao, Ye‐Xuan, Huiwen Zhang, Jing‐Lu Jin, et al.. (2020). Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease. Journal of Lipid Research. 61(9). 1254–1262. 27 indexed citations

Cao, Ye‐Xuan, Huiwen Zhang, Jing‐Lu Jin, et al.. (2020). Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study. Thrombosis and Haemostasis. 121(9). 1161–1168. 16 indexed citations

Wu, Na‐Qiong, Qian Dong, Qiu‐Ting Dong, et al.. (2020). LIPOPROTEIN(A), CORONARY ARTERY CALCIFICATION AND CARDIOVASCULAR EVENTS: A COHORT STUDY FROM CHINA. Journal of the American College of Cardiology. 75(11). 119–119. 1 indexed citations

Zhao, Xi, Huiwen Zhang, Di Sun, et al.. (2019). Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease. Prostaglandins & Other Lipid Mediators. 144. 106345–106345. 10 indexed citations

10.

Zhao, Xi, Di Sun, Rui‐Xia Xu, et al.. (2018). Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study. Biomarkers. 23(7). 647–653. 19 indexed citations

11.

Yang, Shenghua, Ying Du, Yan Zhang, et al.. (2017). Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study. BMJ Open. 7(6). e015041–e015041. 23 indexed citations

12.

Wang, Yao, Cheng‐Gang Zhu, Yuan‐Lin Guo, et al.. (2016). Distribution of ABO Blood Groups and Coronary Artery Calcium. Heart Lung and Circulation. 26(6). 593–598. 6 indexed citations

13.

Ziaeian, Boback, et al.. (2016). The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with Diabetes. Current Diabetes Reports. 16(2). 13–13. 11 indexed citations

14.

Jiang, Yun, et al.. (2015). Identification of Novel Chromosomal Aberrations Induced by 60Co-γ-Irradiation in Wheat-Dasypyrum villosum Lines. International Journal of Molecular Sciences. 16(12). 29787–29796. 12 indexed citations

15.

Zhang, Yan, Sha Li, Rui‐Xia Xu, et al.. (2015). Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography. Mediators of Inflammation. 2015(1). 235742–235742. 12 indexed citations

16.

Zhang, Yan, Cheng‐Gang Zhu, Yuan‐Lin Guo, et al.. (2014). Higher Fibrinogen Level is Independently Linked with the Presence and Severity of New-Onset Coronary Atherosclerosis among Han Chinese Population. PLoS ONE. 9(11). e113460–e113460. 32 indexed citations

17.

Gong, Ping, Xiaolin Li, Yuan‐Lin Guo, et al.. (2014). Relation of ABO blood groups to the severity of coronary atherosclerosis: An Gensini score assessment. Atherosclerosis. 237(2). 748–753. 44 indexed citations

18.

Nie, Xiaomin, et al.. (2013). Kruppel-like factor 2 might mediate the rapamycin-induced arterial thrombosis in vivo: implications for stent thrombosis in patients.. PubMed. 126(14). 2636–40. 4 indexed citations

19.

Guo, Yuan‐Lin, Jun Liu, Rui‐Xia Xu, et al.. (2013). Short-Term Impact of Low-Dose Atorvastatin on Serum Proprotein Convertase Subtilisin/Kexin Type 9. Clinical Drug Investigation. 33(12). 877–883. 47 indexed citations

20.

Zheng, Xin, Jian‐Jun Li, Jinqing Yuan, et al.. (2010). Coronary intervention in patients>or=75 years old with ST-elevation myocardial infarction: in-hospital and 6-month clinical outcomes.. PubMed. 123(16). 2171–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact